Takara Holdings Inc.
Stock Price Chart
2026/11/12 13:15 UpdatedPrice Trend
2026/11/12 13:15 UpdatedPrice & Trading Details
2026/11/12 13:15 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/11/01Shareholder Composition
Updated 2026/11/01Top Mutual Funds / ETFs
Updated 2026/11/01Major Holders
Updated 2026/11/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.4M | -2.48% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.6M | -4.01% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.1M | +1.01% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
720.3K | 0.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
528.5K | -0.40% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd.
|
370.4K | -0.75% |
Dividend History
Updated 2026/11/08| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥31 | 0.0% |
| 2025 | ¥31 | +6.9% |
| 2024 | ¥29 | -23.7% |
| 2023 | ¥38 | +2.7% |
| 2022 | ¥37 | - |
Financial Performance
2026/11/08 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥300,918M | ¥350,665M | ¥339,372M | ¥362,693M |
| Gross Profit | ¥113,541M | ¥119,941M | ¥113,933M | ¥119,647M |
| Operating Income | ¥43,354M | ¥37,945M | ¥22,242M | ¥20,597M |
| Pretax Income | ¥41,291M | ¥40,016M | ¥26,688M | ¥26,515M |
| Net Income | ¥20,769M | ¥21,206M | ¥16,176M | ¥16,202M |
| EPS | ¥105.05 | ¥107.26 | ¥82.09 | ¥82.98 |
| Operating Margin | 14.41% | 10.82% | 6.55% | 5.68% |
| Balance Sheet | ||||
| Total Assets | ¥362,438M | ¥399,174M | ¥437,468M | ¥477,587M |
| Total Equity | ¥180,419M | ¥203,950M | ¥228,663M | ¥245,227M |
| Total Liabilities | ¥182,019M | ¥195,224M | ¥208,805M | ¥232,360M |
| Cash | ¥80,445M | ¥96,820M | ¥95,085M | ¥83,302M |
| Interest-bearing Debt | ¥53,750M | ¥44,557M | ¥67,472M | ¥91,591M |
| Equity Ratio | 49.78% | 51.09% | 52.27% | 51.35% |
| D/E Ratio | 0.30 | 0.22 | 0.30 | 0.37 |
| Cash Flow | ||||
| Operating CF | ¥16,376M | ¥45,478M | ¥29,178M | ¥16,155M |
| Investing CF | -¥10,399M | -¥10,474M | -¥19,993M | -¥41,562M |
| Financing CF | ¥4,133M | -¥22,215M | -¥13,448M | ¥6,548M |
| Free CF | ¥1,614M | ¥34,860M | ¥9,968M | -¥3,988M |
| Efficiency | ||||
| ROE | 11.51% | 10.40% | 7.07% | 6.61% |
| ROA | 5.73% | 5.31% | 3.70% | 3.39% |
Latest IR Information
-
Notice of Revision (Increase) to Consolidated Earnings Forecast and Dividend Forecast for the Fiscal Year Ending March 2027
Revised up consolidated net sales for the fiscal year ending March 2027 from the previous forecast of 420,000 hundred million yen to 430,000 hundred million yen; operating income revised to 21,400 hundred million yen, ordinary income to 19,800 hundred million...
Read more -
Takara Holdings Inc. (Consolidated) Fiscal Year Ending March 2027 Second Quarter (Interim) Financial Summary Supplementary Materials
Consolidated net sales for the second quarter of the fiscal year ending March 2027 were 210,870 million yen (YoY +13.0%), operating income was 13,112 million yen (YoY +68.4%), and interim net income attributable to owners of parent was 11,682 million...
Read more -
Board Opinion on Shareholder Proposals
The board expresses opposition to all shareholder proposals. It emphasizes the appropriateness of the current board composition and supervisory functions, and intends to continue promoting the Mid-Term Management Plan 2030 and revenue structure reforms. It details past dialogue with shareholders...
Read more -
Notice of Extraordinary General Meeting of Shareholders and Board Opinion on Shareholder Proposals
In response to ValueAct's request to convene an extraordinary general meeting, Takara Holdings opposes the removal of three incumbent directors and instead proposes three alternative nominees. The proposed candidates are Eric Johnson, Yuko Tashiro, and Marc-Andre Tousignant. The company emphasizes...
Read more -
Takara Holdings Inc.: Notice Regarding the Succession of Subsidiary Takara Bio Inc.'s GMP Cell Processing Contract Manufacturing Business
A simplified absorption-type split will be implemented to transfer the GMP cell processing contract manufacturing business to S-RACMO, effective January 1, 2027. Takara Bio will concentrate on CDMO areas and optimize its business portfolio, improving efficiency of management resources through...
Read more
Latest News (5 items)
Company Information
About
Takara Holdings Inc., together with its subsidiaries, manufactures and sells alcoholic beverages and seasonings in Japan, the United States, and internationally. It operates through the Takara Shuzo, Takara Shuzo International Group, Takara Bio Group, and Other segments. The company offers alcoholic beverages, including shochu, sake, and light-alcohol refreshers; Scotch whisky, and alcohol-based seasonings, including Hon Mirin, food seasonings, and distilled raw alcohol, as well as engages in the sale of sundries, seafood, wine, bourbon whiskey, food ingredients, frozen food, and cookware and dinnerware for restaurants. It is also involved in the development, manufacture, and sale of reagents and instruments; contract development and manufacturing organization services for the development and manufacturing of regenerative medicine products; genetic analysis and testing; and genetic medicine and gene therapy. In addition, the company engages in the provision of logistics services, such as distribution processing and mail order/sales promotion distribution; transportation; warehousing; automobile services; non-life insurance agent; travel agent; wholesale of containers and packaging materials; digital; printing; and web production. Further, it offers market research; sales promotion planning; temporary staffing, store support, and office and technical work; sale of rice, wheat, and food byproducts, as well as feed comprising rice bran and corn meal; and real estate leasing. The company exports its products. Takara Holdings Inc. was founded in 1842 and is headquartered in Kyoto, Japan.